Support By : Li-lab
PATHWAY_NAME | REACTOME_ID | KEGG_ID | DRUG_NAME | PUBCHEM_CID | Datasource |
---|---|---|---|---|---|
Parkinson's disease | R-HSA-1643685 | 0 | SC-19220 | 2782 | drug-path |
Ribosome | R-HSA-5368277 | map03010 | SC-19220 | 2782 | drug-path |
Graft-versus-host disease | R-HSA-1643685 | map05332 | SC-19220 | 2782 | drug-path |
Pathways in cancer | R-HSA-9824443 | map05200 | SC-19220 | 2782 | drug-path |
Autoimmune thyroid disease | R-HSA-1643685 | map05320 | SC-19220 | 2782 | drug-path |
Circadian rhythm - mammal | R-HSA-400253 | 0 | SC-19220 | 2782 | drug-path |
Asthma | R-HSA-444620 | map05310 | SC-19220 | 2782 | drug-path |
Cytokine-cytokine receptor interaction | R-HSA-6788467 | map04060 | SC-19220 | 2782 | drug-path |
Allograft rejection | R-HSA-9679028 | map05330 | SC-19220 | 2782 | drug-path |
Type I diabetes mellitus | R-HSA-5683209 | map04940 | SC-19220 | 2782 | drug-path |
Huntington's disease | R-HSA-1643685 | 0 | perphenazine | 4748 | drug-path |
Olfactory transduction | R-HSA-9751605 | map04740 | perphenazine | 4748 | drug-path |
MAPK signaling pathway | R-HSA-9652817 | map04010 | perphenazine | 4748 | drug-path |
Ubiquitin mediated proteolysis | R-HSA-983153 | map04120 | danazol | 28417 | drug-path |
Systemic lupus erythematosus | R-HSA-977105 | map05322 | danazol | 28417 | drug-path |
Bladder cancer | R-HSA-9700206 | map05219 | danazol | 28417 | drug-path |
Small cell lung cancer | R-HSA-5619066 | map05222 | danazol | 28417 | drug-path |
T cell receptor signaling pathway | R-HSA-983705 | map04660 | lynestrenol | 5857 | drug-path |
Systemic lupus erythematosus | R-HSA-977105 | map05322 | lynestrenol | 5857 | drug-path |
Fc epsilon RI signaling pathway | R-HSA-2454202 | map04664 | lynestrenol | 5857 | drug-path |